Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
| Brand name | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
| Generic name | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
| Active ingredient(s) | HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM |
| Distributed by / for | Direct Rx Dawsonville, GA 30534 Mfg For: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 a) 30 Tabs |
| NDC | 72189-167-30 |
| Full product label | Losartan Pot./HCTZ 100/12.5 mg Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg For: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 a) 30 Tabs NDC 72189-167-30; b) 90 Tabs NDC 72189-167-90 |
| Recalling firm | Direct Rx |
| Distribution | AL, GA, FL, LA |
| Quantity | 81 bottles |
| Recall initiated | 2022-05-05 |
| Report date | 2022-06-08 |
| Recall completed | 2023-10-05 |
| Recall number | D-0971-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Dawsonville GA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗